SymbNET Metabolomics Workshop for Biologists on metabolomics & the study of host-microbiome interactions.
DATE
06 – 08 Jun 2023
LOCATION
University of Lausanne, Lausanne, Switzerland
https://symbnet.eu/agenda/symbnet-metabolomics-workshop-for-biologists/
'But increasingly the American mortality anomaly, which is still growing, is explained not by the middle-aged or elderly but by the deaths of children and teenagers. One in 25 American 5-year-olds now won’t live to see 40, a death rate about four times as high as in other wealthy nations.'
https://www.nytimes.com/2023/04/06/opinion/deaths-life-expectancy-guns-children.html
TRIM21 is a fascinating molecule - it's basically an intracellular Fc receptor. Here, Mukadam et al show that it plays a role in antibody mediated prevention of tau protein aggregate formation in neurone.
The jump to MHC alleles without described ligands is a promising sign that MixMHC2pred-2.0 could be a powerful tool for both basic and clinical research. Very curious to see if other groups validate and adopt it.
"Within humans, our work revealed that MHC-II binding motifs and MHC-II ligands could be accurately predicted even for alleles without known ligands. This is an important improvement of MixMHC2pred-2.0 compared with MixMHC2pred-1.2 and NeonMHC2, which were not applicable to most patients and could not be included in our benchmarks."
#Immunology
https://www.sciencedirect.com/science/article/pii/S1074761323001292?dgcid=coauthor#sec4
'En unos meses abrirá en Cala Montjoi (Girona) su proyecto más ansiado, por el que lleva esperando, por problemas con las obras, protestas medioambientales y pandemia, ocho años. En junio inaugurará elBulli 1846, un museo que pretende guardar la esencia y la memoria de todo lo vivido durante años en elBulli, cerrado desde 2011, pero que su artífice pretende que no caiga en el olvido, sobre todo para quienes no vivieron aquella locura gastronómica.'
RT @FehrLab
Newest work out of our lab!
SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in mice https://www.biorxiv.org/content/10.1101/2023.04.06.535927v1
@KUMolBio @KUbiology @ResearchAtKU
Frustrated phagocytosis is such an excellent term
Rapid redistribution of clathrin onto macrophage plasma membranes in response to Fc receptor-ligand interaction during frustrated phagocytosis. https://rupress.org/jcb/article-abstract/102/1/55/13322/Rapid-redistribution-of-clathrin-onto-macrophage/
Significant detail regarding #ClarenceThomas failure to disclose multiple gifts of travel from Harlan Crow over the years. In 2004, the LA Times reported on gifts Thomas disclosed he had received from Crow. After this reporting, Thomas didn’t stop accepting gifts from Crow; he just stopped disclosing them. https://www.latimes.com/politics/story/2023-04-06/the-times-reported-about-justice-thomas-gifts-20-years-ago-after-he-just-stopped-disclosing-them #JudicialEthics
Students receive figures with cartoon datasets. They interpret the results, decide on figure order, make a model figure, then write a manuscript explaining the findings. Peer review steps included! 2/
Teaching students to interpret data and write their first scientific paper can be hard!
Our new publication provides all the materials you need to teach these skills in graduate or upper-level undergraduate courses. 1/
https://doi.org/10.24918/cs.2023.14
There are some drawbacks, with monoclonals being more vulnerable to the emergence of escape variants than vaccines, but this is a sensible proposal (the other major drawback is price, but that is a regulatory and not scientific issue).
"As a dual-purpose platform technology, monoclonal antibodies (mAbs) can close the gap in prophylaxis that exists with a vaccine-only approach and serve as a therapeutic option where needed. Thus, the development of an arsenal of ready-to-use prophylactic and therapeutic mAbs could help to rapidly contain future infectious disease outbreaks before they evolve into pandemics."
RT @markus_eichhorn
Join us! Two lectureships (equivalent to Ass Prof) in Environmental Science @uccBEES @UCC in Cork, Ireland. https://www.ucc.ie/en/futures/sustainability/lecturerinenvironmentalscience2posts/
'In this issue of Nature Medicine, Cascone et al.2share the latest results of their phase 2 platform trial, NEOSTAR, which suggest that the addition of CTLA-4 blockade to neoadjuvant anti-PD-1 plus chemotherapy may augment anti-tumor responses.'
#LungCancer #Immunology #TumorImmunology #immunotherapy #checkpointinhibitors
The jump to MHC alleles without described ligands is a promising sign that MixMHC2pred-2.0 could be a powerful tool for both basic and clinical research. Very curious to see if other groups validate and adopt it.
"Within humans, our work revealed that MHC-II binding motifs and MHC-II ligands could be accurately predicted even for alleles without known ligands. This is an important improvement of MixMHC2pred-2.0 compared with MixMHC2pred-1.2 and NeonMHC2, which were not applicable to most patients and could not be included in our benchmarks."
#Immunology
https://www.sciencedirect.com/science/article/pii/S1074761323001292?dgcid=coauthor#sec4
TRIM21 is a fascinating molecule - it's basically an intracellular Fc receptor. Here, Mukadam et al show that it plays a role in antibody mediated prevention of tau protein aggregate formation in neurone.
RT @KurianLab
Join Alavaro, an incredably smart scientist, and a mindful and supportive mentor. https://twitter.com/RadaIglesiasLab/status/1641005339184095235
RT @briscoejames
Job Alert!
Comp bio/bioinformatician wanted for @wellcometrust funded Human Developmental Biology Initiative (HDBI) project
Exciting #HumanDev data & questions working collaboratively with @CorinneHouart @apalexa1 @KatieRLong & us
https://www.crick.ac.uk/careers-study/vacancies/2023-03-27-senior-bioinformatician
I've worked on all of science, from B cells to T cells.
https://fellowsherpa.com